The Oil Search share price rocketed higher on the opening bell and is currently up 17% in early afternoon trading. Here’s why…
The post Why the Oil Search (ASX:OSH) share price is shooting 17% higher today appeared first on Motley Fool Australia. –
The Oil Search Limited (ASX: OSH) share price rocketed higher on the opening bell today and is currently up more than 17% in early afternoon trading.
That compares to a 2% gain for the wider S&P/ASX 200 Index (ASX: XJO).
Today’s gains continue what’s proven to be an excellent month for Oil Search. So far in November, the Oil Search share price is up nearly 29%. Though it still has a long way to go before recouping the losses it suffered following the COVID-19 induced panic selling earlier this year.
Year to date, Oil Search shares remain down 53%.
What does Oil Search do?
Oil Search was established in Papua New Guinea in 1929 and began trading on the ASX in 1999. The company operates all of PNG’s oil fields. It owns 29% of the Exxon Mobil Corporation (NYSE: XOM) operated PNG LNG Project, a major exporter to Asian markets. The company also holds interests in the Elk-Antelope and P’nyang gas fields.
Oil Search counts some of the most successful oil and gas operators in the world as its joint venture partners. With PNG’s world class fossil fuel assets, the company is well-positioned to expand its LNG capacity.
Why is the Oil Search share price shooting higher?
As with all energy shares, the Oil Search share price doesn’t solely rest on how efficiently the company is operating. It’s also reliant on the price of oil and gas, and on investors’ estimate of how future demand will impact that price.
Today, Oil Search is getting a boost on both fronts.
Brent crude oil prices are up 7.5% in past 24 hours, to US$42.40 per barrel.
And with investors hopeful that the new vaccine will reopen global economies, the outlook for future energy demand paints a stronger potential picture for the price of oil and gas going forward.
Addressing the news of a possible vaccine on energy markets, Stewart Glickman, energy equity analyst at CFRA Research said (quoted by Bloomberg):
This changes everything on the demand side. Assuming it can be produced commercially, it makes it very viable for people to take more risks knowing they have a vaccine.
Michael Tran, a commodity strategist at RBC Capital Markets LLC adds:
At a minimum, what today’s news has done is put a floor into the oil market, pushing short sellers away. This is a significant step in the right direction, but there’s still headwinds at play … the duration between now and when demand actually returns is still an open-ended question.
As we get a better idea on the reality and timing of rolling out an effective COVID vaccine, the Oil Search share price will be one to watch.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
- 5 things to watch on the ASX 200 on Tuesday
- 5 things to watch on the ASX 200 on Friday
- 5 things to watch on the ASX 200 on Wednesday
- ASX 200 finished 2% higher on Tuesday
- Why Laybuy, Oil Search, PointsBet, & Webjet shares are racing higher
Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.